Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase III, Placebo-Controlled, Multi-Center Study to Examine theSafety and Efficacy of Multiple-Dose Intravitreal Injections of rhuFabV2 in Subjects with Age-Related Macular Degeneration who have Predominant Classic Lesion Degeneration
ranibizumab
FVF2587G
NCT00061594
Neovascular Age-related Macular Degeneration
Phase 3
 
December 2015

Powered by ideaPoint, Inc.